Our study developed, for the first time, a hypoxia specific scFv Ab binding to HCC by phage library selection, and revealed that its antigen PKM2 is a potential biomarker for hypoxia in liver cancer tissues. The gene discussed is PKM; the disease is hepatocellular carcinoma.